Fas-independent and nonapoptotic cytotoxicity mediated a human CD4+ T- cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide

Blood

Volumn 93, Issue 3, 1999, Pages 925-935

  Ohminami, Hideki ^b   Yasukawa, Masaki ^a   Kaneko, Shin ^b   Yakushijin, Yoshihiro ^b   Abe, Yasuhito ^b   Kasahara, Yoshihito ^b   Ishida, Yasushi ^b   Fujita, Shigeru ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD4 ANTIGEN; CONCANAMYCIN A; FAS ANTIGEN; FAS LIGAND; GRANZYME B; HYBRID PROTEIN; IDOXURIDINE; LYMPHOTOXIN; MESSENGER RNA; PERFORIN; STRONTIUM; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; AGAR GEL ELECTROPHORESIS; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE MUTATION; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032950188     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.3.925.403k32_925_935     Document Type: Article

References (54)

1. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G: The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 12:1687, 1992
2. Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatsch C, Heinze B, Bartram C, Hagemeijer A, Grosveld G: The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 79:2990, 1992
3. Henkart PA: Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1:343, 1994
4. Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H: Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14:207, 1996
5. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993
6. Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31, 1994
7. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
8. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650, 1994
9. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MTF, Young JDE, Ahmed R, Clark WR: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 91:10854, 1994
10. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K, Shinkai Y, Alt FW, Matsuzawa A, Yonehara S, Takayama H: Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357, 1994
11. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J: Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 183:657, 1996
12. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER: Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 157:1919, 1996
13. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53:45, 1988
14. Abe Y, Miyake M, Horiuchi A, Kimura S, Hitsumoto Y: Expression of membrane-associated lymphotoxin/tumor necrosis factor-β on human lymphokine-activated killer cells. Jpn J Cancer Res 82:23, 1991
15. Browning JL, Androlewicz MJ, Ware CF: Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J Immunol 147:1230, 1991
16. + T cell-mediated cytotoxicity. J Immunol 152:1127, 1994
17. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K: Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 91:4930, 1994
18. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185, 1994
19. Kasahara Y, Wada T, Niida Y, Yachie A, Seki H, Ishida Y, Sakai T, Koizumi F, Koizumi S, Miyawaki T, Taniguchi N: Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol 10:195, 1998
20. + T cells. J Immunol 146:1341, 1991
21. Sugden B, Mark W: Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 23:503, 1977
22. + human cytotoxic T cell clones directed against herpes simplex virus. J Immunol 140:3419, 1988
23. Kataoka T, Shinohara N, Takamiya H, Takaku K, Kondo S, Yonehara S, Nagai K: Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 156:3678, 1996
24. ++-induced inhibition of human natural killer (NK) cell-mediated cytotoxiciy. J Immunol 128: 1236, 1982
25. Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, Rosat J-P, Sette A, Brenner MB, Porcelli SA, Bloom BR, Modlin RL: Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684, 1997
26. Miyake M, Horiuchi A, Kimura K, Abe Y, Kimura S, Hitsumoto Y: Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells. Eur J Immunol 22:2147, 1992
27. + human cytotoxic T cell clones. Clin Immunol Immunopathol 78:70, 1996
28. Takayama H, Shinohara N, Kawasaki A, Someya Y, Hanaoka S, Kojima H, Yagita H, Okumura K, Shinkai Y: Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones. Int Immunol 3:1149, 1991
29. Carding SR, Lu D, Bottomly K: A polymerase chain reaction assay for the detection and quantitation of cytokine gene expression in small numbers of cells. J Immunol Methods 151:277, 1992
30. Kobayashi H, Kokubo T, Abe Y, Sato K, Kimura S, Miyokawa N, Katagiri M: Analysis of anchor residules in a naturally processed HLA-DR53 ligand. Immunogenetics 44:366, 1996
31. Lowin B, Mattman C, Hahne M, Tschopp J: Comparison of Fas (Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. J Immunol 8:57, 1996
32. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M: Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158:5283, 1997
33. + human cytotoxic T-cell clones. Blood 81:1527, 1993
34. +. Proc Natl Acad Sci USA 79:2365, 1982
35. Yasukawa M, Zarling JM: Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol 133:422, 1984
36. Tite JP, Janeway Jr CA: Cloned helper T cells can kill B lymphoma cells in the presence of speciific antigen: Ia restriction and cognate vs. noncognate interactions in cytolysis. Eur J Immunol 14:878, 1984
37. Nakamura M, Ross DT, Briner TJ, Gefter ML: Cytolytic activity of antigen-specific T cells with helper phenotype. J Immunol 136:44, 1986
38. Ozaki S, York-Jolly Y, Kawamura H, Berzofsky JA: Cloned protein antigen-specific, Ia-restricted T cells with both helper and cytolytic activities: Mechanisms of activation and killing. Cell Immunol 105:301, 1987
39. + human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 133:754, 1984
40. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
41. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton JA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
42. + human T-cell clones. J Virol 66:2773, 1992
43. + human CTL clones induced by candidate AIDS vaccines. J Immunol 153:2787, 1994
44. + CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 156:153, 1996
45. + T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. J Immunol 158:2756, 1997
46. Duke RC, Persechini PM, Chang S, Liu C-C, Cohen JJ, Young JD-E: Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med 170:1451, 1989
47. Simon MM, Hausmann M, Tran T, Ebnet K, Tschopp J, ThaHla R, Müllbacher A: In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A X B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med 186:1781, 1997
48. Shresta S, Russell JH, Ley TJ: Mechanisms resposible for granzyme B-independent cytotoxicity. Blood 89:4085, 1997
49. + cytolytic T lymphocyte clones: Evidence for a TNF-α-independent cytolytic mechanism. J Immunol 148:3789, 1992
50. + T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur J Immunol 25:2588, 1995
51. + T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer 72:784, 1997
52. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88:3522, 1996
53. Alsabeh R, Brynes RK, Slovak ML, Arber DA: Acute myeloid leukemia with t(6;9) (p23;q34): Association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol 107:430, 1997
54. Dirks W, Schöne S, Uphoff C, Quentmeier H, Pradella S, Drexler HG: Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br J Haematol 96:584, 1997